Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers

por Bihani, Teeru, Ezell, Scott A., Ladd, Brendon, Grosskurth, Shaun E., Mazzola, Anne Marie, Pietras, Mark, Reimer, Corinne, Zinda, Michael, Fawell, Stephen, D'Cruz, Celina M.
Publicado 2014

Generation of stable PDX derived cell lines using conditional reprogramming

por Borodovsky, Alexandra, McQuiston, Travis J., Stetson, Daniel, Ahmed, Ambar, Whitston, David, Zhang, Jingwen, Grondine, Michael, Lawson, Deborah, Challberg, Sharon S., Zinda, Michael, Pollok, Brian A., Dougherty, Brian A., D’Cruz, Celina M.
Publicado 2017

Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activation

por Henry, Ryan E., Barry, Evan R., Castriotta, Lillian, Ladd, Brendon, Markovets, Aleksandra, Beran, Garry, Ren, Yongxin, Zhou, Feng, Adam, Ammar, Zinda, Michael, Reimer, Corinne, Qing, Weiguo, Su, Weiguo, Clark, Edwin, D'Cruz, Celina M., Schuller, Alwin G.
Publicado 2016

Effective combination therapies in preclinical endocrine resistant breast cancer models harboring ER mutations

por Ladd, Brendon, Mazzola, Anne Marie, Bihani, Teeru, Lai, Zhongwu, Bradford, James, Collins, Michael, Barry, Evan, Goeppert, Anne U., Weir, Hazel M., Hearne, Kelly, Renshaw, Jonathan G., Mohseni, Morvarid, Hurt, Elaine, Jalla, Sanjoo, Bao, Haifeng, Hollingsworth, Robert, Reimer, Corinne, Zinda, Michael, Fawell, Stephen, D'Cruz, Celina M.
Publicado 2016